Consistent with these functional findings, decreased SNRNP40 transcript-level expression in bulk primary breast cancer samples was associated with increased metastatic relapse outcomes in multiple independent data sets (Fig. 8e–g). This evidence concerns the gene SNRNP40 and breast cancer.